Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg (Extended Release) Tablets

Send Inquiry

Request To Call Back

Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg (Extended Release) Tablets

Name: Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg (Extended Release) Tablets
Brand: STERIS HEALTHCARE PRIVATE LIMITED
Price: 150.0 INR
Availability: InStock

Price 150.0 INR/ Strip

Get a Price/Quote

MOQ : 1 Strip

Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg (Extended Release) Tablets Specification

Indication
Type 2 Diabetes Mellitus

Life Span
24 Months

Origin of Medicine
INDIA

Dosage Form
Extended Release (ER) Tablets

Pacakaging (Quantity Per Box)
10X15 TAB

Salt Composition
Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg (Extended Release) Tablets

Brand Name
GLIDAPA TENMET 1000

Packaging Type
Strip / Blister Pack

Drug Type
Other

Ingredients
GLIDAPA TENMET 1000 is a modern and effective combination medication designed for the management of Type 2 Diabetes Mellitus. It contains Dapagliflozin 10 mg, Teneligliptin 20 mg, and Metformin Hydrochloride 1000 mg (Extended Release) a powerful triple-action formula that helps control blood sugar levels through complementary mechanisms. This advanced combination is ideal for patients who require multi-drug therapy to achieve optimal glycemic control. By targeting different pathways involved in glucose regulation, GLIDAPA TENMET 1000 not only helps reduce blood sugar levels but also supports long-term metabolic health and reduces the risk of diabetes-related complications. Uses GLIDAPA TENMET 1000 is primarily used for the treatment of Type 2 Diabetes Mellitus, especially in patients who are not adequately controlled with diet, exercise, or single/dual therapy. It helps in: Lowering high blood glucose levels Improving insulin sensitivity Reducing glucose reabsorption in kidneys Enhancing incretin hormone activity for better insulin release Supporting overall glycemic control This medication is typically prescribed as part of a comprehensive diabetes management plan that includes a healthy diet and regular physical activity. Benefits The combination of Dapagliflozin, Teneligliptin, and Metformin Hydrochloride Extended Release provides multiple benefits: Triple Mechanism Action Targets blood sugar through kidney excretion, insulin secretion, and reduced glucose production in the liver. Effective Glycemic Control Helps maintain stable blood sugar levels throughout the day. Weight Management Support Dapagliflozin may aid in mild weight reduction by eliminating excess glucose through urine. Improved Patient Compliance Three medicines combined into one tablet reduce pill burden. Cardiovascular and Renal Benefits Supports heart and kidney health in diabetic patients. Extended Release Advantage Metformin ER ensures sustained glucose control with fewer gastrointestinal side effects. Dosage The dosage of GLIDAPA TENMET 1000 should be strictly followed as prescribed by a healthcare professional. Usually taken once daily, preferably with meals to minimize stomach discomfort. Swallow the tablet whole with water; do not crush or chew, as it is an extended-release formulation. Maintain consistent timing each day for best results. Important tips: Monitor blood glucose levels regularly. Follow dietary and lifestyle recommendations alongside medication. Do not skip doses or discontinue without consulting your doctor. Side Effects While GLIDAPA TENMET 1000 is generally well-tolerated, some patients may experience mild to moderate side effects: Nausea or stomach discomfort Frequent urination (due to Dapagliflozin) Headache or dizziness Low blood sugar (especially when combined with other antidiabetic medicines) Genital or urinary tract infections Rare but serious side effects may include lactic acidosis (associated with Metformin), severe dehydration, or allergic reactions. Immediate medical attention is required if symptoms like severe weakness, difficulty breathing, or swelling occur. Precautions and Warnings Before starting GLIDAPA TENMET 1000, consider the following precautions: Kidney Function: Patients with impaired kidney function should use this medication cautiously. Liver Disorders: Inform your doctor if you have liver disease. Hydration: Maintain adequate fluid intake to avoid dehydration. Alcohol Consumption: Limit alcohol intake, as it may increase the risk of side effects like lactic acidosis. Pregnancy & Breastfeeding: Use only if prescribed by a doctor. Infections: Monitor for signs of urinary or genital infections. Patients should also inform their healthcare provider about any other medications or supplements they are taking to avoid potential drug interactions. Conclusion GLIDAPA TENMET 1000 is a highly effective triple-combination therapy that offers comprehensive blood sugar control for patients with Type 2 Diabetes Mellitus. With the combined power of Dapagliflozin, Teneligliptin, and Metformin Hydrochloride Extended Release, it addresses multiple aspects of diabetes management, ensuring better outcomes and improved quality of life. When used as prescribed along with a balanced diet and regular exercise, GLIDAPA TENMET 1000 can help patients achieve stable glucose levels, reduce complications, and maintain long-term health. It stands as a reliable and advanced solution for modern diabetes care.

Physical Form
Tablets

Function
Other

Recommended For
Adults with Type 2 Diabetes

Dosage
One tablet daily (usually with a meal)

Dosage Guidelines
To be swallowed whole; do not crush or chew

Suitable For
Adults

Quantity
15 Tablets Strip

Storage Instructions
Store below 30 C in a dry place. Protect from light.

Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg (Extended Release) Tablets Trade Information

Minimum Order Quantity
1 Strip

Delivery Time
4 Days

About Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg (Extended Release) Tablets

GLIDAPA TENMET 1000 is a modern and effective combination medication designed for the management of Type 2 Diabetes Mellitus. It contains Dapagliflozin 10 mg, Teneligliptin 20 mg, and Metformin Hydrochloride 1000 mg (Extended Release)a powerful triple-action formula that helps control blood sugar levels through complementary mechanisms.

This advanced combination is ideal for patients who require multi-drug therapy to achieve optimal glycemic control. By targeting different pathways involved in glucose regulation, GLIDAPA TENMET 1000 not only helps reduce blood sugar levels but also supports long-term metabolic health and reduces the risk of diabetes-related complications.

Uses

GLIDAPA TENMET 1000 is primarily used for the treatment of Type 2 Diabetes Mellitus, especially in patients who are not adequately controlled with diet, exercise, or single/dual therapy.

It helps in:

Lowering high blood glucose levels
Improving insulin sensitivity
Reducing glucose reabsorption in kidneys
Enhancing incretin hormone activity for better insulin release
Supporting overall glycemic control

This medication is typically prescribed as part of a comprehensive diabetes management plan that includes a healthy diet and regular physical activity.

Benefits

The combination of Dapagliflozin, Teneligliptin, and Metformin Hydrochloride Extended Release provides multiple benefits:

Triple Mechanism Action Targets blood sugar through kidney excretion, insulin secretion, and reduced glucose production in the liver.
Effective Glycemic Control Helps maintain stable blood sugar levels throughout the day.
Weight Management Support Dapagliflozin may aid in mild weight reduction by eliminating excess glucose through urine.
Improved Patient Compliance Three medicines combined into one tablet reduce pill burden.
Cardiovascular and Renal Benefits Supports heart and kidney health in diabetic patients.
Extended Release Advantage Metformin ER ensures sustained glucose control with fewer gastrointestinal side effects.

Dosage

The dosage of GLIDAPA TENMET 1000 should be strictly followed as prescribed by a healthcare professional.

Usually taken once daily, preferably with meals to minimize stomach discomfort.
Swallow the tablet whole with water; do not crush or chew, as it is an extended-release formulation.
Maintain consistent timing each day for best results.

Important tips:

Monitor blood glucose levels regularly.
Follow dietary and lifestyle recommendations alongside medication.
Do not skip doses or discontinue without consulting your doctor.

Side Effects

While GLIDAPA TENMET 1000 is generally well-tolerated, some patients may experience mild to moderate side effects:

Nausea or stomach discomfort
Frequent urination (due to Dapagliflozin)
Headache or dizziness
Low blood sugar (especially when combined with other antidiabetic medicines)
Genital or urinary tract infections

Rare but serious side effects may include lactic acidosis (associated with Metformin), severe dehydration, or allergic reactions. Immediate medical attention is required if symptoms like severe weakness, difficulty breathing, or swelling occur.

Precautions and Warnings

Before starting GLIDAPA TENMET 1000, consider the following precautions:

Kidney Function: Patients with impaired kidney function should use this medication cautiously.
Liver Disorders: Inform your doctor if you have liver disease.
Hydration: Maintain adequate fluid intake to avoid dehydration.
Alcohol Consumption: Limit alcohol intake, as it may increase the risk of side effects like lactic acidosis.
Pregnancy & Breastfeeding: Use only if prescribed by a doctor.
Infections: Monitor for signs of urinary or genital infections.

Patients should also inform their healthcare provider about any other medications or supplements they are taking to avoid potential drug interactions.

Conclusion

GLIDAPA TENMET 1000 is a highly effective triple-combination therapy that offers comprehensive blood sugar control for patients with Type 2 Diabetes Mellitus. With the combined power of Dapagliflozin, Teneligliptin, and Metformin Hydrochloride Extended Release, it addresses multiple aspects of diabetes management, ensuring better outcomes and improved quality of life.

When used as prescribed along with a balanced diet and regular exercise, GLIDAPA TENMET 1000 can help patients achieve stable glucose levels, reduce complications, and maintain long-term health. It stands as a reliable and advanced solution for modern diabetes care.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in Diabetic Range Category

Glimepiride (3mg)

Price 210 INR / Box

Minimum Order Quantity : 1 Box

Physical Form : Tablets

Storage Instructions : Cool and dry place

Dosage Guidelines : Direction by physician

Get a Price/Quote

Metformin Hydrochloride Prolonged-release 850 mg and Glimepiride IP 2 mg Tablets

Price 70.0 INR / Piece

Minimum Order Quantity : 1 Piece

Physical Form : Tablets

Storage Instructions : Store below 25 C

Dosage Guidelines : Usually taken once daily with or after meals

Ingredients : Diabetes mellitus, especially Type 2 diabetes, is a growing health concern in India due to changing lifestyles, dietary habits, and reduced physical activity. Effective longterm blood sugar management often requires combination therapy that works through multiple mechanisms. SEIZMET G2 850 is a scientifically formulated oral antidiabetic medicine containing Metformin Hydrochloride ProlongedRelease 850 mg and Glimepiride IP 2 mg. This combination helps achieve better glycaemic control while minimizing fluctuations in blood sugar levels. The prolongedrelease form of metformin ensures sustained action throughout the day, making SEIZMET G2 850 a reliable choice for patients who need consistent diabetes management. Uses SEIZMET G2 850 is primarily prescribed for the management of Type 2 Diabetes Mellitus in adults when diet and exercise alone are not sufficient to control blood glucose levels. It is especially useful in patients who require dual therapy to manage fasting as well as postmeal blood sugar. The medicine may be recommended for patients with insulin resistance, obesityassociated diabetes, or those who have not achieved adequate control with monotherapy. Benefits One of the key benefits of SEIZMET G2 850 is its dual mechanism of action. Metformin reduces glucose production in the liver and improves insulin sensitivity, while glimepiride stimulates insulin release from the pancreas. The prolongedrelease formulation of metformin helps reduce gastrointestinal discomfort and provides steady glucose control throughout the day. Regular use, as advised by a doctor, can help lower HbA1c levels, reduce the risk of diabetesrelated complications, and improve overall metabolic health. SEIZMET G2 850 also supports better weight management compared to some other antidiabetic therapies, making it suitable for longterm use. Dosage The dosage of SEIZMET G2 850 should be strictly followed as prescribed by a physician. Generally, it is taken once daily with or after meals to reduce the risk of stomach upset and hypoglycaemia. The tablet should be swallowed whole and not crushed or chewed, as this may affect the prolongedrelease mechanism. Dosage adjustments depend on individual blood sugar levels, kidney function, and treatment response. Regular monitoring of blood glucose is essential during therapy. Side Effects Like all medicines, SEIZMET G2 850 may cause some side effects, though not everyone experiences them. Common side effects include nausea, mild stomach upset, diarrhoea, headache, and dizziness. In some cases, patients may experience low blood sugar levels, especially if meals are skipped or excessive physical activity is performed. Rare but serious side effects include lactic acidosis, particularly in patients with kidney or liver problems. Immediate medical attention is advised if symptoms such as extreme weakness, breathing difficulty, or unusual drowsiness occur. Precautions and Warning SEIZMET G2 850 should be used with caution in patients with kidney disease, liver disorders, heart conditions, or a history of alcohol abuse. It is not recommended for patients with Type 1 diabetes or diabetic ketoacidosis. Alcohol consumption should be avoided during treatment, as it may increase the risk of hypoglycaemia and lactic acidosis. Pregnant and breastfeeding women should use this medicine only if clearly advised by a doctor. Regular monitoring of kidney function, liver enzymes, and blood sugar levels is essential during prolonged therapy. Conclusion SEIZMET G2 850 offers an effective and balanced approach to managing Type 2 diabetes by combining the benefits of metformin prolongedrelease and glimepiride. Its sustained glucoselowering action, improved tolerability, and proven efficacy make it a dependable choice for longterm diabetes care. When used alongside a healthy diet, regular exercise, and medical supervision, SEIZMET G2 850 helps patients maintain stable blood sugar levels and improve their overall quality of life.

Get a Price/Quote